Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Completed · Phase 3 · Has a placebo group

Conditions studied: Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Lamotrigine may be effective in reducing pain, numbness, tingling, and other symptoms of peripheral neuropathy. It is not yet known whether lamotrigine is effective in treating peripheral neuropathy caused by chemotherapy. PURPOSE: This randomized phase III trial is studying how well lamotrigine works in reducing pain, numbness, tingling, and other symptoms of peripheral neuropathy caused by chemotherapy in patients with cancer.

Key facts

Study ID
NCT00068445
Run by
Alliance for Clinical Trials in Oncology
People needed
131
Starts
2004-02-01
Expected to finish
2013-11-01
Last updated by the study team
2018-05-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.